Ligand Pharmaceuticals Statistics
Total Valuation
LGND has a market cap or net worth of $6.33 billion. The enterprise value is $7.03 billion.
| Market Cap | 6.33B |
| Enterprise Value | 7.03B |
Important Dates
The last earnings date was Thursday, October 29, 2026, before market open.
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
LGND has 20.00 million shares outstanding. The number of shares has increased by 10.50% in one year.
| Current Share Class | 20.00M |
| Shares Outstanding | 20.00M |
| Shares Change (YoY) | +10.50% |
| Shares Change (QoQ) | -8.59% |
| Owned by Insiders (%) | 2.23% |
| Owned by Institutions (%) | 116.19% |
| Float | 19.55M |
Valuation Ratios
The trailing PE ratio is 132.25 and the forward PE ratio is 45.16. LGND's PEG ratio is 1.85.
| PE Ratio | 132.25 |
| Forward PE | 45.16 |
| PS Ratio | 24.92 |
| Forward PS | 18.06 |
| PB Ratio | 6.58 |
| P/TBV Ratio | 14.00 |
| P/FCF Ratio | 69.81 |
| P/OCF Ratio | 69.50 |
| PEG Ratio | 1.85 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 98.40, with an EV/FCF ratio of 77.60.
| EV / Earnings | 136.67 |
| EV / Sales | 27.71 |
| EV / EBITDA | 98.40 |
| EV / EBIT | 192.65 |
| EV / FCF | 77.60 |
Financial Position
The company has a current ratio of 1.22, with a Debt / Equity ratio of 1.20.
| Current Ratio | 1.22 |
| Quick Ratio | 1.16 |
| Debt / Equity | 1.20 |
| Debt / EBITDA | 16.01 |
| Debt / FCF | 12.74 |
| Interest Coverage | 4.46 |
Financial Efficiency
Return on equity (ROE) is 5.38% and return on invested capital (ROIC) is 2.96%.
| Return on Equity (ROE) | 5.38% |
| Return on Assets (ROA) | 1.23% |
| Return on Invested Capital (ROIC) | 2.96% |
| Return on Capital Employed (ROCE) | 2.10% |
| Weighted Average Cost of Capital (WACC) | 8.52% |
| Revenue Per Employee | $5.40M |
| Profits Per Employee | $1.09M |
| Employee Count | 47 |
| Asset Turnover | 0.14 |
| Inventory Turnover | 2.67 |
Taxes
In the past 12 months, LGND has paid $1.27 million in taxes.
| Income Tax | 1.27M |
| Effective Tax Rate | 2.41% |
Stock Price Statistics
The stock price has increased by +51.54% in the last 52 weeks. The beta is 1.04, so LGND's price volatility has been similar to the market average.
| Beta (5Y) | 1.04 |
| 52-Week Price Change | +51.54% |
| 50-Day Moving Average | 301.33 |
| 200-Day Moving Average | 257.80 |
| Relative Strength Index (RSI) | 55.44 |
| Average Volume (20 Days) | 215,841 |
Short Selling Information
The latest short interest is 2.50 million, so 12.51% of the outstanding shares have been sold short.
| Short Interest | 2.50M |
| Short Previous Month | 2.68M |
| Short % of Shares Out | 12.51% |
| Short % of Float | 12.80% |
| Short Ratio (days to cover) | 9.25 |
Income Statement
In the last 12 months, LGND had revenue of $253.83 million and earned $51.46 million in profits. Earnings per share was $2.39.
| Revenue | 253.83M |
| Gross Profit | 218.61M |
| Operating Income | 36.51M |
| Pretax Income | 52.73M |
| Net Income | 51.46M |
| EBITDA | 71.48M |
| EBIT | 36.51M |
| Earnings Per Share (EPS) | $2.39 |
Balance Sheet
The company has $447.40 million in cash and $1.15 billion in debt, with a net cash position of -$706.81 million or -$35.34 per share.
| Cash & Cash Equivalents | 447.40M |
| Total Debt | 1.15B |
| Net Cash | -706.81M |
| Net Cash Per Share | -$35.34 |
| Equity (Book Value) | 961.76M |
| Book Value Per Share | 48.09 |
| Working Capital | 107.67M |
Cash Flow
In the last 12 months, operating cash flow was $91.03 million and capital expenditures -$405,000, giving a free cash flow of $90.63 million.
| Operating Cash Flow | 91.03M |
| Capital Expenditures | -405,000 |
| Depreciation & Amortization | 34.97M |
| Net Borrowing | 504.18M |
| Free Cash Flow | 90.63M |
| FCF Per Share | $4.53 |
Margins
Gross margin is 86.12%, with operating and profit margins of 14.38% and 20.27%.
| Gross Margin | 86.12% |
| Operating Margin | 14.38% |
| Pretax Margin | 20.77% |
| Profit Margin | 20.27% |
| EBITDA Margin | 28.16% |
| EBIT Margin | 14.38% |
| FCF Margin | 35.70% |
Dividends & Yields
LGND does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -10.50% |
| Shareholder Yield | -10.50% |
| Earnings Yield | 0.76% |
| FCF Yield | 1.43% |
Analyst Forecast
The average price target for LGND is $361.27, which is 14.23% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $361.27 |
| Price Target Difference | 14.23% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (3Y) | 18.60% |
| EPS Growth Forecast (3Y) | 19.84% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
The last stock split was on November 19, 2010. It was a reverse split with a ratio of 1:6.
| Last Split Date | Nov 19, 2010 |
| Split Type | Reverse |
| Split Ratio | 1:6 |
Scores
LGND has an Altman Z-Score of 2.72 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.72 |
| Piotroski F-Score | 5 |